Isolation and structural identification of glycopolymers of Bifidobacterium bifidum BIM B-733D as putative players in pathogenesis of autoimmune thyroid diseases

Beneficial Microbes

Volumn 4, Issue 4, 2013, Pages 375-391

  Kiseleva, E P ^a   Mikhailopulo, K I ^a   Novik, G I ^b   Szwajcer Dey, E ^c   Zdorovenko, E L ^d   Shashkov, A S ^d   Knirel, Y A ^d  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Belarus)

^b INSTITUTE OF MICROBIOLOGY   (Belarus)

^c LUND UNIVERSITY   (Sweden)

^d N D ZELINSKY INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Autoantibodies; Molecular mimicry; 1,6 glucan

Indexed keywords

BIOPOLYMER; CARBOHYDRATE; DEXTRAN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

AFFINITY CHROMATOGRAPHY; ARTICLE; AUTOIMMUNE THYROID DISEASE; BACTERIUM ISOLATION; BIFIDOBACTERIUM BIFIDUM; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; MOLECULAR MIMICRY; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PROTON NUCLEAR MAGNETIC RESONANCE; REFRACTOMETRY; THYROID DISEASE;

AUTOANTIBODIES; MOLECULAR MIMICRY; Α-1,6-GLUCAN;

ANTIGENS, BACTERIAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIFIDOBACTERIUM; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; HUMANS; IODIDE PEROXIDASE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR WEIGHT; POLYSACCHARIDES, BACTERIAL; PROTEIN BINDING; THYROGLOBULIN; THYROID DISEASES;

EID: 84891588241     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0015     Document Type: Article

References (105)

1. Agadjanyan, M., Luo, P., Westerink, M.A.J., Carey, L.A., Hutchins, W.,Steplewski, Z., Weiner, D.B. and Kieber-Emmons, T., 1997. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nature Biotechnology 15: 547-551.
2. Al-Zarzour, N. and Monem, F., 2011. Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Journal of Infection in Developing Countries 5: 890-892.
3. Anikhovskaya, I.A., Vyshegurov, Y.K., Likhoded, V.G. and Yakovlev,M.Y., 2005. Increased titers of antibodies to bifidobacteria as a marker of intestinal dysbacteriosis. Human Physiology 31: 235-236.
4. Anonymous, 1976. Affinity chromatography. Principles and methods.Pharmacia Fine Chemicals, Uppsala, Sweden.
5. Atkinson, M.A., Bowman, M.A., Campbell, L., Darrow, B.L., Kaufman,D.L. and Maclaren, N.K., 1994. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulindependent diabetes. Journal of Clinical Investigation 94: 2125-2129.
6. Beever, K., Bradbury, J., Phillips, D., McLachlan, S.M., Pegg, C., Goral,A., Overbeck, W., Feifel, G. and Smith, B.R., 1989. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clinical Chemistry 35: 1949-1954.
7. Benvenga, S., Santarpia, L., Trimarchi, F. and Guarneri, F., 2006. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16: 225-236.
8. Borchers, A.T., Selmi, C., Meyers, F.J., Keen, C.L. and Gershwin,M.E., 2009. Probiotics and immunity. Journal of Gastroenterology 44: 26-46.
9. Buist, G., Ridder, A.N., Kok, J. and Kuipers, O.P., 2006. Different subcellular locations of secretome components of Gram-positive bacteria. Microbiology 152: 2867-2874.
10. Burek, C.L. and Talor, M.V., 2009. Environmental triggers of autoimmune thyroiditis. Journal of Autoimmunity 33: 183-189.
11. Canaris, G.J., Manowitz, N.R., Mayor, G. and Ridgway, E.C., 2000. The Colorado thyroid disease prevalence study. Archives of Internal Medicine 160: 526-534.
12. Caturegli, P., Kuppers, R.C., Mariotti, S., Burek, C.L., Pinchera, A.,Ladenson P.W. and Rose, N.R., 1994. IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clinical and Experimental Immunology 98: 464-469.
13. Chiovato, L., Bassi, P., Santini, F., Mammoli, C., Lapi, P., Carayon, P. and Pinchera, A., 1993. Antibodies producing complementmediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. Journal of Clinical Endocrinology and Metabolism 77: 1700-1705.
14. Cisar, J., Kabat, E.A., Dorner, M.M. and Liao, J., 1975. Binding properties of immunoglobulin combining sites specific for terminal or nonterminal antigenic determinants in dextran. Journal of Experimental Medicine 142: 435-459.
15. Cooper G.S. and Stroehla B.C., 2003. The epidemiology of autoimmune diseases. Autoimmunity Reviews 2: 119-125.
16. Cunningham, M.W., 2000. Pathogenesis of group A streptococcal infections. Clinical Microbiology Reviews 13: 470-511.
17. Dai, Y.D., Eliades, P., Carayanniotis, K.A., McCormick, D.J., Kong, Y.M.,Magafa, V., Cordopatis, P., Lymberi, P. and Carayanniotis, J., 2005.Thyroxine-binding antibodies inhibit T cell epitope recognition of a pathogenic thyroglobulin. Journal of Immunology 174: 3105-3110.
18. Dale, J.B. and Beachey, E.H., 1985. Multiple, heart-cross-reactive epitopes of streptococcal M proteins. Journal of Experimental Medicine, 161: 113-122.
19. Davies T.F. and Amino N., 1993. A new classification for human autoimmune thyroid disease. Thyroid 3: 331-333.
20. Davies, T.F., 2008. Infection and autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism 93: 674-676.
21. De Man, J.D., Rogosa, M. and Sharpe, M.E., 1960. A medium for the cultivation of lactobacilli. Journal of Applied Bacteriology 23:130-135.
22. De Vrese, M. and Schrezenmeir, J., 2008. Probiotics, prebiotics, and synbiotics. Advances in Biochemical Engineering / Biotechnology 111: 1-66.
23. Delcenserie, V., Martel, D., Lamoureux, M., Amiot, J., Boutin, Y. and Roy, D., 2008. Immunomodulatory effects of probiotics in the intestinal tract. Current Issues in Molecular Biology 10: 37-54.
24. Den Dunnen, J., Gringhuis, S.I. and Geijtenbeek, T.B., 2010. Dusting the sugar fingerprint: C-type lectin signaling in adaptive immunity. Immunology Letters 128: 12-16.
25. Duntas, L.H., 2008. Environmental factors and autoimmune thyroiditis. Endocrinology and Methabolism 4: 454-460.
26. Ercolini A.M. and Miller S.D., 2009. The role of infections in autoimmune disease. Clinical and Experimental Immunology 155: 1-15.
27. Estienne, V., Duthoit, C., Costanzo, V.D., Lejeune, P. J., Rotondi, M.,Kornfeld, S., Finke, R., Lazarus J.H., Feldt-Rasmussen, U., Franke,W.G., Smyth, P., D'Herbomez M., Conte-Devolx, B., Persani, L.,Carella, C., Jourdain, J.R., Izembart, M., Toubert, M.E., Pinchera, A.,Weetman, A., Sapin, R., Carayon, P. and Ruf, J., 1999. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters. European Journal of Endocrinology 141: 563-569.
28. Ezendam, J. and Van Loveren, H., 2006. Immune effects of the probiotic Bifidobacterium breve. RIVM report 340320006. National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
29. Fenouillet, F., Fayet, G., Hovsepian, S., Bahraoui, E.M. and Ronin, C.,1986. Immunochemical evidence for a role of complex carbohydrate chains in thyroglobulin antigenicity. Journal of Biological Chemistry 261: 15153-15158.
30. Foti, D. and Rapoport, B., 1990. Carbohydrate moieties in recombinant human thyroid peroxidase: role in recognition by antithyroid peroxidase antibodies in Hashimoto's thyroiditis. Endocrinology 126: 2983-2988.
31. Gaisford, W. and Cooke, A., 2009. Can infections protect against autoimmunity? Current Opinion in Rheumatology 21: 391-396.
32. Gautam, A. M., Liblau, R., Chelvanayagam, G., Steinman, L. and Boston, T., 1998. A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis. Journal of Immunology 161: 60-64.
33. Getts, M.T. and Miller, S.D., 2010. 99th Dahlem conference on infection,inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clinical and Experimental Immunology 160: 15-21.
34. Gill, H.S., Rutherfurd, K.J., Prasad, J. and Gopal, P.K., 2000.Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). British Journal of Nutrition 83:167-176.
35. Giraud, A., Franc, J.-L., Long, Y. and Ruf, J., 1992. Effects of deglycosylation of human thyroperoxidase on its enzymatic activity and immunoreactivity. Journal of Endocrinology 132: 317-323.
36. Guilherme, L., Kalil, J. and Cunningham, M., 2006. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39: 31-39.
37. Harkiolaki, M., Holmes, S.L., Svendsen, P., Gregersen, J.W., Jensen, L.T.,McMahon, R., Friese, M.A., Van Boxel, G., Etzensperger, R., Tzartos,J.S., Kranc, K., Sainsbury, S., Harlos, K., Mellins, E.D., Palace, J., Esiri,M.M., Van der Merwe, P.A., Jones, E.Y. and Fugger, L., 2009. T cellmediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30: 348-357.
38. Heimburg-Molinaro, J., Almogren, A., Morey, S., Glinskii, O.V., Roy,R., Wilding, G.E., Cheng, R.P., Glinsky, V.V. and Rittenhouse-Olson,K., 2009. Development, characterization and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen. Neoplasia 11: 780-792.
39. Herkel, J., Erez-Alon, N., Mimran, A., Wolkowicz, R., Harmelin,A., Ruiz, P., Rotter, V. and Cohen, I.R., 2000. Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA. European Journal of Immunology 30: 977-984.
40. Hoshioka, A., Kohno, Y. and Niimi, H., 1994. Identification and immunopathogenicity of a common T cell epitope between human thyroglobulin and human thyroid peroxidase. Nippon Rinsho /Japanese Journal of Clinical Medicine 52: 1063-1068.
41. Jeong, E. and Lee, J.Y., 2011. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Medical Journal 52: 379-392.
42. Katona-Durekovic, A., 2007. The role of virus infections in the pathogenesis of type 1 diabetes - a case report. Medicinski Pregled 60: 397-400.
43. Kawai, T. and Akira, S., 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. International Immunology 21: 317-337.
44. Kindt, T., Goldsby, R. and Osborne, B., 2007. Immunology. W.H.Freeman and Company, New York, NY, USA.
45. Kiseleva, E.P., Mikhailopulo, K.I., Sviridov, O.V., Novik, G.I., Knirel,Y.A. and Szwajcer Dey, E., 2011. The role of components of Bifidobacterium and Lactobacillus in pathogenesis and serologic diagnosis of autoimmune thyroid diseases. Beneficial Microbes 2: 139-154.
46. Kiso, Y., Furmaniak, J., Morteo, C. and Rees Smith, B., 1992. Analysis of carbohydrate residues on human thyroid peroxidase (TPO) and thyroglobulin (Tg) and effects of deglycosylation, reduction and unfolding on autoantibody binding. Autoimmunity 12: 259-269.
47. Kivity, S., Agmon-Levin, N., Blank, M. and Shoenfeld, Y., 2009.Infections and autoimmunity - friends or foes? Trends in Immunology 30: 409-414.
48. Kobayashi, T., Kato, I., Nanno, M., Shida, K., Shibuya, K., Matsuoka,Y. and Onoue, M., 2010. Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacology and Immunotoxicology 32: 116-124.
49. Kohm, A.P., Carpentier, P.A. and Miller, S.D., 2003. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+regulatory T cells. Novartis Foundation Symposium 252: 45-52.
50. Kohno, Y., Naito, N., Hiyama, Y., Shimojo, N., Suzuki, N., Tarutani,O., Niimi, H., Nakajima, H. and Hosoya, T., 1988. Thyroglobulin and thyroid peroxidase share common epitopes recognized by autoantibodies in patients with chronic autoimmune thyroiditis. The Journal of Clinical Endocrinology and Metabolism 67: 899-907.
51. Licciardi, P.V. and Tan, M.L.K., 2011. Vaccine adjuvant properties of probiotic bacteria. Discovery Medicine 12: 525-533.
52. Lindberg, B., Svensson, J., Ericsson, U. B., Nilsson, P., Svenonius, E.and Ivarsson, S.A., 2001. Comparison of some different methods for analysis of thyroid autoantibodies: importance of thyroglobulin autoantibodies. Thyroid 11: 265-269.
53. Liu, M., Yue, X., Dai, Z., Ma, Y., Xing, L., Zha, Z., Liu, S. and Li, Y.,2009. Novel thrombo-resistant coating based on iron-polysaccharide complex multilayers. Applied Materials and Interfaces 1: 113-123.
54. Lleo, A., Invernizzi, P., Gao, B., Podda, M. and Gershwin, E., 2010.Definition of human autoimmunity - autoantibodies versus autoimmune disease. Autoimmunity Reviews 9: A259-A266.
55. Luo, P., Agadjanyan M., Qiu J., Westerink, M.A., Steplewski, Z. and Kieber-Emmons, T., 1998. Antigenic and immunological mimicryof peptide mimotopes of Lewis carbohydrate antigens. Molecular Immunology 35: 865-879.
56. Luo, P., Canziani, G., Cunto-Amesty, G. and Kieber-Emmons, T., 2000.A molecular basis for functional peptide mimicry of a carbohydrate antigen. Journal of Biological Chemistry 275: 16146-16154.
57. Martocchia, A. and Falaschi, P., 2007. Amino acid sequence homologies between HCV polyprotein and thyroid antigens. Internal and Emergency Medicine 2: 65-67.
58. McLachlan, S.M. and Rapoport, B., 1989. Evidence for a potential common T-cell epitope between human thyroid peroxidase and human thyroglobulin with implications for the pathogenesis of autoimmune thyroid disease. Autoimmunity 5: 101-106.
59. Moura, E.G., Pazos-Moura, C.C., Yokoyama, N., Dorris, M.L. and Taurog, A., 1991. Enzymatic deglycosylation of porcine thyroid peroxidase: effects on catalytic activity and immunoreactivity. Acta Endocrinologica 124: 107-114.
60. Münz, C., Lünemann, J.D., Getts, M.T. and Miller, S.D., 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews Immunology 9: 246-258.
61. Neiser, S., Wilhelm, M., Schwarz, K., Funk, F., Geisser, P. and Burckhardt, S., 2011. Assessment of dextran antigenicity of intravenous iron products by an immunodiffusion assay. Portuguese Journal of Nephrology and Hypertension 25: 219-224.
62. Novik, G.I., Astapovich, N.I., Samartsev, A.A. and Riabaia, N.E.,1997. Isolation and characteristics of a protein-polysaccharide complex, secreted by Bifidobacterium adolescentis. Mikrobiologiya 66: 621-627.
63. Oldstone, M.B., 1998. Molecular mimicry and immune-mediated diseases. FASEB Journal 12: 1255-1265.
64. Paul, A., Geetha, M., Chacko, B.K. and Appukuttan, P.S., 2009. Multiple specificity of human serum dextran-binding immunoglobulin:alpha (1→6)- and beta (1→3)-linked glucose and alpha (1→3)-linked galactose in natural glycoconjugates are recognized. Immunological Investigations 38: 153-164.
65. Popkova, S.?., Shmeleva, ?.?., Leschuk, S.I., Serduk, L.V. and Kichigina, E.L., 2007. Dysbacteriosis as consequence of disturbances of immune tolerance to endogenous microflora. Bulletin of East-Siberian Scientific Center of SD RAMS 3S: 57-62 (In Russian).
66. Pordeus, V., Szyper-Kravitz, M., Levy, R.A., Vaz, N.M. and Shoenfeld,Y., 2008. Infections and autoimmunity: a panorama. Clinical Reviews in Allergy and Immunology 34: 283-299.
67. Potluková, E. and Limanová, Z., 2007. The role of complement in autoimmune thyroid disorders. Casopis lékaru ceskỳch 146: 210-214 (in Czech).
68. Qader, S.A.U.L., Iqbal, L., Aman, A., Shireen, E. and Azhar, A. 2005.Production of dextran by newly isolated strains of Leuconostoc mesenteroides PCSIR-4 and PCSIR-9. Turkish Journal of Biochemistry 31: 21-26.
69. Rebuffat, S.A., Nguyen, B., Robert, B., Castex, F. and Peraldi-Roux,S., 2008. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism 93: 929-934.
70. Reid, G., Jass, J., Sebulsky, T. and McCormick, J.K., 2003. Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews 16: 658-672.
71. Ringold, D.A., Nicoloff, J.T., Kesler, M., Davis, H., Hamilton, A. and Mack, T., 2002. Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid 12: 647-653.
72. Roep, B.O., 2003. Molecular mimicry in autoimmune neurological disease after viral infection. Current Medicinal Chemistry 10:1939-1943.
73. Root-Bernstein, R., Vonck, J. and Podufaly, A., 2009. Antigeniccomplementarity between coxsackie virus and streptococcus in the induction of rheumatic heart disease and autoimmune myocarditis. Autoimmunity 42: 1-16.
74. Rose, N.R., 2008. The adjuvant effect in infection and autoimmunity. Clinical Reviews in Allergy and Immunology 34: 279-282.
75. Ruf, J., Feldt-Rasmussen, U., Hegedüs, L., Ferrand, M. and Carayon, P.,1994. Bispecific thyroglobulin and thyroperoxidase autoantibodies in patients with various thyroid and autoimmune diseases. Journal of Clinical Endocrinology and Metabolism 79: 1404-1409.
76. Sack J., Zilberstein, D., Barile, M.F., Lukes, Y.G., Baker, J.R., Wartofsky,L. and Burman, K.D., 1989. Binding of thyrotropin to selected Mycoplasma species: detection of serum antibodies against a specific Mycoplasma membrane antigen in patients with autoimmune thyroid disease. Journal of Endocrinological Investigation 12: 77-86.
77. Salamero, J., Remy, J.J., Michel-Bechet, M. and Charreire, J., 1987.Experimental autoimmune thyroiditis induced by a 5-10-kDa tryptic fragment from porcine thyroglobulin. European Journal of Immunology 17: 843-848.
78. Sarwat, F., Qader, S.A.U., Aman, A. and Ahmed, N., 2008. Production and characterization of a unique dextran from an indigenous Leuconostoc mesenteroides CMG713. International Journal of Biological Sciences 4: 379-386.
79. Schäffer, C. and Messner, P., 2005. The structure of secondary cell wall polymers: how Gram-positive bacteria stick their cell walls together. Microbiology 151: 643-651.
80. Schäffer, C., Graninger, M. and Messner, P., 2001. Prokaryotic glycosylation. Proteomics 1: 248-261.
81. Shakib, F. and Stanworth, D.R., 1980. Human IgG subclasses in health and disease. Part I. La Ricerca in Clinica e in Laboratorio 10: 463-479.
82. Simionescu, L., Zamfir-Grigorescu, D., Dimitriu, V. and Aman, E.,1983. An improved procedure for the preparation of the human thyroglobulin and the development of a thyroglobulin autoantibody kit. Endocrinologie 21: 113-121.
83. Simmonds, M.J. and Gough, S.C.L., 2004. Unraveling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clinical and Experimental Immunology 136: 1-10.
84. Slack, E., Hapfelmeier, S., Stecher, B., Velykoredko, Y., Stoel, M.,Lawson, M.A., Geuking, M.B., Beutler, B., Tedder, T.F., Hardt,W.D., Bercik, P., Verdu, E.F., McCoy, K.D. and Macpherson, A.J.,2009. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325: 617-620.
85. Thomas, D., Karachaliou, F., Kallergi, K., Vlachopapadopoulou, E.,Antonaki, G., Chatzimarkou, F., Fotinou, A., Kaldrymides, P. and Michalacos, S., 2008a. Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease. Endocrine 33: 171-175.
86. Thomas, D., Liakos, V., Michou, V., Kapranos, N., Kaltsas, G., Tsilivakos,V. and Tsatsoulis, A., 2008b. Detection of herpes virus DNA in postoperative thyroid tissue specimens of patients with autoimmune thyroid disease. Experimental and Clinical Endocrinology and Diabetes 116: 35-39.
87. Thrasyvoulides, A. and Lymberi, P., 2004. Antibodies cross-reacting with thyroglobulin and thyroid peroxidase are induced by immunization of rabbits with an immunogenic thyroglobulin 20mer peptide. Clinical and Experimental Immunology 138: 423-429.
88. Tomer Y. and Villanueva, R., 2004. Infection and autoimmune thyroid diseases. In: Shoenfeld, Y. and Rose, N.R. (eds.) Infection and autoimmunity. Elsevier, Amsterdam, the Netherlands, pp. 515-530.
89. Tomer, Y., 2010. Genetic susceptibility to autoimmune thyroid disease:past, present, and future. Thyroid 20: 715-725.
90. Tozzoli, R., Barzilai, O., Ram, M., Villalta, D., Bizzaro, N., Sherer, Y. and Shoenfeld, Y., 2008. Infections and autoimmune thyroid diseases:parallel detection of antibodies against pathogens with proteomic technology. Autoimmunity Reviews 8: 112-115.
91. Tsyganova, O.V., Kiseleva, E.P., Vashkevich, I.I. and Sviridov, O.V.,2006a. Isolation of autoantibodies to human thyroid peroxidase by antigen-affinity chromatography and their application in immunoassay. Proceedings of the National Academy of Sciences of Belarus, Series of Chemical Sciences 2006: 64-71 (in Russian).
92. Tsyganova, O.V., Kiseleva, E.P., Vashkevich, I.I., Priadko, A.G.and Sviridov, O.V., 2006b. Characteristics of immunoaffinity chromatography and a new method for isolation of human thyroid peroxidase from subcellular fractions of thyroid gland. Applied Biochemistry and Microbiology 42: 236-246.
93. Tsyganova, O.V., Kiseleva, E.P., Vashkevich, I.I., Priadko, A.G. and Sviridov, O.V., 2006c. Characteristics of monoclonal antibodies against human thyroid peroxidase for use in immunoaffinity chromatography and immunoassays. Applied Biochemistry and Microbiology 42: 98-105.
94. Vanderpump, M.P., Turnbridge, W.N., French, J.M., Appleton, D., Bates,D., Clark, F., Grimley Evans, J., Hasan, D.M., Rodgers, H., Tunbridge, F.T. and Young, E.T., 1995. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clinical Endocrinology 43: 55-68.
95. Vinderola, C.G., Medici, M. and Perdigon, G., 2004. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. Journal of Applied Microbiology 96: 230-243.
96. Von Herrath, M.G., Fujinami, R.S. and Whitton, J.L., 2003.Microorganisms and autoimmunity: making the barren field fertile?Nature Reviews 1: 151-157.
97. Wagenfeld, K., 1991. Occurrence of bifidobacteria in the stool of multiple sclerosis patients. Zentralblatt für Bakteriologie 275:541-548.
98. Wegner, N., Wait, R. and Venables, P.J., 2009. Evolutionarily conserved antigens in autoimmune disease: implications for an infective aetiology. International Journal of Biochemistry and Cell Biology 41: 390-397.
99. Wohlgemuth, S., Loh, G. and Blaut. M., 2010. Recent developments and perspectives in the investigation of probiotic effects. International Journal of Medical Microbiology 300: 3-10.
100. Xie, L.-D., Gao, Y., Li, M.-R., Lu, G.-Z. and Guo, X.-H., 2008.Distribution of immunoglobulin G subclasses of anti-Thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status. Clinical and Experimental Immunology 154: 172-176.
101. Zeuthen, L.H., Fink L.N. and Frøkiær, H., 2008. Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology 124: 489-502.
102. Zhang, M., Cui, S.W., Cheung, P.C.K. and Wang, Q., 2007. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends in Food Science and Technology 18: 4-19.
103. Zhang, X., Rimpilainen, M., Hoffmann, B., Simelyte, E., Aho, H.and Toivanen, P., 2001. Experimental chronic arthritis and granulomatous inflammation induced by Bifidobacterium cell walls. Scandinavian Journal of Immunology 54: 171-179.
104. Zhang, Y., Gao, Y., Li, M., Xie, L., Huang, Y., Gao, Y. and Guo X.,2010. Avidity of thyroglobulin antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status. Clinical and Experimental Immunology 161: 65-70.
105. Zhou, J.S. and Gill, H.S., 2005. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. International Journal of Food Microbiology 103: 97-104.